This HTML5 document contains 103 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80100963
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'ochobre de 2006 наукова стаття, опублікована в жовтні 2006 scientific article published on 01 October 2006 wetenschappelijk artikel im Oktober 2006 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2006
p:P577
wds:Q80100963-107C2330-DBF3-4B41-92E9-258EBBA5F22F
wdt:P577
2006-10-01T00:00:00Z
p:P2860
wds:Q80100963-F818F069-9E80-4BEE-ADDF-8A221483EB19 wds:Q80100963-E5D2E6FB-C5C4-4ACF-847B-2ADEF39DB2EC wds:Q80100963-3D110468-3186-4E1D-8411-5A9EB3613BE0 wds:Q80100963-3F2AF88F-96BD-439E-909A-EB5EF166D288 wds:Q80100963-410409E8-931C-42FC-B36D-CA6CDD9BEE3C wds:Q80100963-52311549-F2F7-465C-9FA5-AE32D76BB0A5 wds:Q80100963-558F07DB-E822-4E09-AD20-93FD8A70634A wds:Q80100963-63D1D1AA-271D-4F3A-AF33-E0636E025914 wds:Q80100963-0E510EF2-D57C-4793-8BCC-3453B0EEE1B3 wds:Q80100963-1079EAFD-2C5C-4DA5-937B-EE42B546AC20 wds:Q80100963-203A60C4-6A13-42BF-8D7E-4590428D35CB wds:Q80100963-297647F7-C307-4D8D-ACB9-C1C1D645DC60 wds:Q80100963-93FE98BC-86C4-4A34-94E4-F977E137C482 wds:Q80100963-9BAF4CAC-D362-4560-AD84-ACCCF0B73709 wds:Q80100963-A66FA913-FB07-405D-AA33-77C997106AC7 wds:Q80100963-ADDCFC02-BDC1-4DE8-AF80-0BA0A8E77259 wds:Q80100963-B587711A-DCF5-4996-BD04-4D7F42FDAB4C wds:Q80100963-6D2DBEFA-9B92-4DE3-B992-A931D0DDEA1F wds:Q80100963-7955351C-26D5-4A70-A1D6-6444452AD600 wds:Q80100963-79F3B041-886B-4F2F-937D-5D684ECAE285 wds:Q80100963-83A6CF0A-DDA1-427C-85A6-88A6522CEADE wds:Q80100963-8AB05B35-DD2E-4E96-99CD-1F4B12552F30 wds:Q80100963-0578A3CC-3D43-422D-B0E8-8FF9D77D7EE6
wdt:P2860
wd:Q27824812 wd:Q46443638 wd:Q27860904 wd:Q29615475 wd:Q34533636 wd:Q47378801 wd:Q29620605 wd:Q36144700 wd:Q35956595 wd:Q29547546 wd:Q29396936 wd:Q46735180 wd:Q34557318 wd:Q53521886 wd:Q28274882 wd:Q34271566 wd:Q33218784 wd:Q44968652 wd:Q46585170 wd:Q36821859 wd:Q36346977 wd:Q53450591 wd:Q44936060
p:P2093
wds:Q80100963-BEC77383-45B3-4459-A98C-D9409E77B3E4 wds:Q80100963-BF338A15-C102-4016-9CD6-D2FB87E13E7A wds:Q80100963-7A619E5E-CEB6-4238-B0AE-3649F784C6AC wds:Q80100963-58288A7E-3F13-4EBB-859C-037A4AF8DD15 wds:Q80100963-1AB223E8-0DE8-4074-8BE1-B8FA5993E5D3 wds:Q80100963-FAE6B4AC-5089-41F9-A28A-21C345EEC2DC wds:Q80100963-E08BA239-37F1-4F20-A67E-EC89889B9700 wds:Q80100963-D6D0A859-01CA-4463-ACE1-7C3867B3DE2F wds:Q80100963-DC20454F-1DB5-4951-97C4-ED44BFC1FAFB wds:Q80100963-D6960DCC-C232-4D8E-A52C-ED38DDFB8AFB wds:Q80100963-0CF2EB45-329D-4760-90A1-3CABDA5D7F63
wdt:P2093
Purvish Parikh Reury-Perng Perng Eng Huat Tan Nick Botwood Domingo Ganzon Chih-Hsin Yang Sumitra Thongprasert Nick Thatcher Alex Chang Claire Watkins Chao-Jung Tsao
rdfs:label
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study
skos:prefLabel
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study
schema:name
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study
p:P1476
wds:Q80100963-8C3FAAF0-34F1-47EE-B463-B53DA5470509
wdt:P1476
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study
p:P304
wds:Q80100963-2F306BD6-F0B3-4B27-85AE-2432ACE5B9EE
wdt:P304
847-855
p:P31
wds:Q80100963-16D7B8C5-A3A9-46B4-9AD5-DAF6D86F72E5
wdt:P31
wd:Q13442814
p:P921
wds:Q80100963-D33DFDF1-AE2F-460D-9680-DB2833F616FF
wdt:P921
wd:Q47912
p:P698
wds:Q80100963-8E3EE8E3-EE09-4BE1-A3FB-3C22A2F3B190
wdtn:P698
n11:17409969
wdt:P698
17409969
p:P1433
wds:Q80100963-8EE1C998-F20E-400B-AD39-EC734B85FD2A
wdt:P1433
wd:Q2448056
p:P433
wds:Q80100963-E7C518D6-ED6E-4083-A151-1728637551FF
p:P478
wds:Q80100963-F77C8B3B-D86C-4470-BD64-8FD4565CEC41
wdt:P433
8
wdt:P478
1
p:P356
wds:Q80100963-27B74BF1-6D0D-47EC-B3D3-2C0F18E194C0
wdtn:P356
n10:S1556-0864(15)30415-9
wdt:P356
10.1016/S1556-0864(15)30415-9